1. Home
  2. UCL vs INO Comparison

UCL vs INO Comparison

Compare UCL & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UCL
  • INO
  • Stock Information
  • Founded
  • UCL 2014
  • INO 1979
  • Country
  • UCL Hong Kong
  • INO United States
  • Employees
  • UCL N/A
  • INO N/A
  • Industry
  • UCL Telecommunications Equipment
  • INO Medical/Dental Instruments
  • Sector
  • UCL Consumer Discretionary
  • INO Health Care
  • Exchange
  • UCL Nasdaq
  • INO Nasdaq
  • Market Cap
  • UCL 144.5M
  • INO 136.6M
  • IPO Year
  • UCL 2020
  • INO 1998
  • Fundamental
  • Price
  • UCL $2.18
  • INO $2.43
  • Analyst Decision
  • UCL
  • INO Buy
  • Analyst Count
  • UCL 0
  • INO 5
  • Target Price
  • UCL N/A
  • INO $8.80
  • AVG Volume (30 Days)
  • UCL 26.6K
  • INO 1.0M
  • Earning Date
  • UCL 11-25-2025
  • INO 11-10-2025
  • Dividend Yield
  • UCL N/A
  • INO N/A
  • EPS Growth
  • UCL N/A
  • INO N/A
  • EPS
  • UCL 0.02
  • INO N/A
  • Revenue
  • UCL $89,277,000.00
  • INO $182,337.00
  • Revenue This Year
  • UCL N/A
  • INO N/A
  • Revenue Next Year
  • UCL $20.86
  • INO $14,751.49
  • P/E Ratio
  • UCL $95.30
  • INO N/A
  • Revenue Growth
  • UCL 3.72
  • INO N/A
  • 52 Week Low
  • UCL $0.80
  • INO $1.30
  • 52 Week High
  • UCL $4.19
  • INO $5.80
  • Technical
  • Relative Strength Index (RSI)
  • UCL 45.45
  • INO 60.39
  • Support Level
  • UCL $2.15
  • INO $2.44
  • Resistance Level
  • UCL $2.39
  • INO $2.67
  • Average True Range (ATR)
  • UCL 0.13
  • INO 0.13
  • MACD
  • UCL 0.04
  • INO 0.01
  • Stochastic Oscillator
  • UCL 48.28
  • INO 94.50

About UCL uCloudlink Group Inc.

Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Share on Social Networks: